Category: Latest News

M&T Bank Corporation (NYSE:MTB) saw its shares tick up 0.39% in premarket trading on Wednesday after reporting better-than-expected results for the second quarter. The Buffalo-headquartered lender delivered adjusted earnings of $4.28 per share, topping analyst projections of $3.99. Total revenue for the quarter came in at $2.4 billion, slightly ahead of the $2.39 billion forecast.…

In a note released Wednesday, Bank of America analysts suggested that quantum computing “could be the biggest revolution for humanity since discovering fire.” They argued that this groundbreaking technology has the potential to upend existing global power structures and spark an era of extraordinary innovation. “A human would have to perform one sum every second…

Johnson & Johnson (NYSE:JNJ) has increased its full-year sales outlook, even amid concerns about potential U.S. tariffs on pharmaceutical imports. The company now projects annual revenue between $93.2 billion and $93.6 billion, up from the previous estimate of $91 billion to $91.8 billion. Shares of Johnson & Johnson climbed over 1% in early U.S. trading…

Shares of Global Payments (NYSE:GPN) surged over 6% in premarket trading on Wednesday following media reports that activist investor Elliott Investment Management has acquired a significant stake in the fintech company. According to sources familiar with the situation, Elliott’s holding in the Atlanta-based payment processor is described as “sizable.” However, Reuters noted that the exact…

Shares of J.B. Hunt Transport Services (NASDAQ:JBHT) dipped over 1% in early U.S. trading on Wednesday after the transportation and logistics company reported second-quarter results that exceeded Wall Street expectations, despite ongoing pressures from volume and pricing challenges. J.B. Hunt posted earnings of $1.31 per share on revenues of $2.93 billion, slightly surpassing analyst forecasts…

AstraZeneca’s (NYSE:AZN) rare disease division, Alexion, announced that its experimental treatment anselamimab did not achieve the primary objective in a significant late-stage study targeting patients with a severe and rare cardiac condition, causing the company’s stock to decline on Wednesday. The Phase III CARES trial revealed that anselamimab failed to demonstrate a statistically significant advantage…

The U.S. dollar edged lower on Wednesday, retreating from a recent rally as markets digested consumer price data and looked ahead to a key report on producer inflation for further signals on Federal Reserve policy. By 04:55 ET (08:55 GMT), the Dollar Index — which monitors the dollar’s movement against six major global currencies —…

Producer prices in the United States remained flat in June, according to data published Wednesday by the Labor Department, surprising analysts who had anticipated a modest increase. The Producer Price Index (PPI) for final demand was unchanged last month, following a revised 0.3% rise in May. Economists had forecast a 0.2% gain, compared to the…